Home
>
National Drug Code (NDC)
>
Cevimeline
Cevimeline - 63304-479-01 - (Cevimeline)
Drug Information of Cevimeline
| Product NDC: | 63304-479 |
| Proprietary Name: | Cevimeline |
| Non Proprietary Name: | Cevimeline |
| Active Ingredient(s): | 30 mg/1 & nbsp; Cevimeline |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cevimeline
| Product NDC: | 63304-479 |
| Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020989 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121007 |
Package Information of Cevimeline
| Package NDC: | 63304-479-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (63304-479-01) |
NDC Information of Cevimeline
| NDC Code | 63304-479-01 |
| Proprietary Name | Cevimeline |
| Package Description | 100 CAPSULE in 1 BOTTLE (63304-479-01) |
| Product NDC | 63304-479 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cevimeline |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20121007 |
| Marketing Category Name | NDA |
| Labeler Name | Ranbaxy Pharmaceuticals Inc. |
| Substance Name | CEVIMELINE HYDROCHLORIDE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] |
